IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Mahamaya Lifesciences IPO is a book build IPO listing on BSE SME exchange. The company is based in New Delhi and caters to Chemical - Pesticides sector. Oneview Corporate Advisors Private is the merchant banker of Mahamaya Lifesciences IPO. It is a SME UPCOMING IPO which filed its Draft Red Herring Prospectus (DRHP) on 27th February 2025.
Mahamaya Lifesciences IPO open date is [●] and close date is [●]. IPO Allotment Date is [●] and Listing date is [●].Mahamaya Lifesciences IPO size is Rs [●] crores with IPO price of Rs [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Oneview Corporate Advisors Private Limited is the book-running lead manager of the Mahamaya Lifesciences IPO. KFin Technologies Limited is the Registrar and Market Maker is [●] for Mahamaya Lifesciences IPO.
Mahamaya Lifesciences IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Mahamaya Lifesciences IPO, based in New Delhi, operates in the Chemical - Pesticides sector with a focus on . The company is launching its SME UPCOMING IPO on the BSE SME exchange, using the Book Building Issue method. Mahamaya Lifesciences IPO size is ₹ [●] Crores with fresh issue size of Rs [●] Crores and Offer for sale being Nil.
The IPO allotment date for Mahamaya Lifesciences IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Mahamaya Lifesciences IPO allotment status on the registrars website, KFin Technologies Limited. Mahamaya Lifesciences IPO refund dates are [●].
Mahamaya Lifesciences IPO is expected to be listed on [●].
The upper price band for the Mahamaya Lifesciences IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Mahamaya Lifesciences IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Mahamaya Lifesciences IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Mahamaya Lifesciences IPO is finalised.
The merchant banker for Mahamaya Lifesciences IPO is Oneview Corporate Advisors Private Limited . Oneview Corporate Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Mahamaya Lifesciences IPO RHP for further details.
The registrar for Mahamaya Lifesciences IPO is KFin Technologies Limited. Investors can go to KFin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Mahamaya Lifesciences IPO through their official website or helpline.
Mahamaya Lifesciences IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
[●]
Avg IPO Size (Sector Based)
:
[●]
Sector: Chemical - Pesticides
SME IPO so far:
5
Merchant Banker:
Oneview Corporate
SME IPO by BRLM so far:
47
City:
New Delhi
SME IPO so far:
57
Revenue (annualised):
₹ 292.46 cr.
PE
Ratio:
[●]
Average Sector PE Ratio: [●]
Mahamaya Lifesciences IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Mahamaya Lifesciences Financial Review Page
Merchant Banker(s) of Mahamaya Lifesciences IPO: Oneview Corporate Advisors Private Limited
Mahamaya Lifesciences IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Mahamaya Lifesciences IPO listed at a listing price of against the offer price of .
The current market price of Mahamaya Lifesciences is .
Why Us?
